Unlocking the matrix barrier in fibrotic diseases.
Tandem Therapeutics AG
Incorporated
02.06.2023Headquarters
SchlierenSupport
Most drug development is focused on targeting cells, overlooking the extracellular matrix that surrounds the cells. Presence of excessive matrix proteins are linked to therapeutic resistance and poor patient outcomes in fibrotic tumors and organ fibrosis. The matrix offers druggable biological real-estate to targets nodes that drive disease progression. At Tandem Therapeutics our goal is to precision target this barrier and bring drugs to this disease extracellular matrix thereby enhancing safety and efficacy. Using evolutionarily optimised peptides, we are decoding complex matrix-disease biology to create breakthrough solutions for patients burdened with fibrotic diseases.
News
The most promising Swiss biotech startups and scale-ups of 2024, according to investors (TOP 100)
Sustainable start-ups excel at the W.A de Vigier Award (startupticker.ch)
Wyss Zurich expands portfolio (startupticker.ch)
Tandem Therapeutics joins Wyss Zurich Translational Center to accelerate progress in fibrosis treatment (venturelab.swiss)
The top 15 startups in de Vigier Award revealed (startupticker.ch)
Venture Leaders Biotech 2023: Captain’s Blog by Navignostics, Mosanna Therapeutics, Limula, and Tandem Therapeutics (venturelab.swiss)
The Venture Leaders Biotech set sail on the Boston roadshow with immersive expert workshops, uniting entrepreneurs and investors in the US market (venturelab.swiss)
Tandem Therapeutics: The Venture Leader Biotech focusing on precision targeting the extracellular matrix barrier in fibrotic cancers (venturelab.swiss)
Venture Leaders Biotech kick off their Boston roadshow at Swiss Biotech Day (venturelab.swiss)
Swiss National Startup Team 2023: 10 biotech innovators are headed to Boston (venturelab.swiss)
Tandem Therapeutics wins CHF 150,000 to advance fight against fibrotic cancer (venturekick.ch)
CHF 40,000 for rebuilding coral reefs, making sustainable fishing bait, and targeting diseased microenvironment in fibrosis (venturekick.ch)
